The 7th
Annual
NC
Undergraduate
Summer Research Symposium
National Institutes of
Health Undergraduate Scholarship Program (UGSP)
Abstracts are listed in
alphabetical order by the last name of the corresponding author.
|
Tran, Andy P. |
|
|
Home Institution: |
National Cancer Institute
& NCSU |
|
Program: |
National Institutes of Health Undergraduate
Scholarship Program (UGSP) |
|
College: |
PAMS |
|
Department(s): |
National Cancer Institute
- Medical Oncology Branch |
|
Research |
Christine M.
Hollander/National Cancer Institute Larry Blanton/University
Honors Program |
|
Title of Presentation: |
Evaluation of PH-domain
Specificity of a New Akt Inhibitor |
Lung cancer kills more than 170,000 people each year
and it is the leading cause of cancer deaths in the United States. Of these
lung cancer cases, 80% are identified as non-small cell lung cancer (NSCLC) and
20% are small cell lung cancer (SCLC). Recent studies show biochemical
alterations such as activations of certain signal transduction pathways may be
responsible for carcinogenesis and resistance to therapy. The activation of Akt-mTOR (serine/threonine kinase-mammalian target of rapamycin)
pathway at S473 leads to the propagation of signals that are vital to cellular
processes such as transcription, translation, cell cycle progression, and
apoptosis. The role of this pathway in carcinogenesis and therapy resistance
has inspired scientists to develop novel inhibitors that prevent the growth of
tumors. Recent inhibitors of Akt at the ATP binding
site have been shown to prevent tumor growth and also elicit potent cytotoxicity in vivo. However, these inhibitors often
target multiple protein kinases because they share
similarities in ATP binding sites. To address this, our group is developing a
novel inhibitor that targets Akt at its pleckstrin homology (PH) domain. Using a virtual screening
protocol, we have identified potential inhibitors of Akt
from the ChemNavigator database. Our data shows that
our lead compound, N-11 elicits favorable cytotoxicity
in vitro against a number of cancer cell lines. Also, further experiments
suggest that N-11’s inhibitory effects on Akt
are through binding at its PH domain causing a displacement of Akt membrane localization and inactivation of this cancer
pathway.
[ Participant Listing
| Abstracts ]
Last modified June 2008 by Sharon E. Hunt